1. Escalation Versus Induction/High-Efficacy Treatment Strategies for Relapsing Multiple Sclerosis: Which is Best for Patients?

   • Gilles Edan
   • Emmanuelle Le Page

   Current Opinion Open access 19 September 2023 Pages: 1351 - 1363

2. Treatment of Ovarian Cancer Beyond PARP Inhibition: Current and Future Options

   • Vikas Garg
   • Amit M. Oza

   Review Article Open access 22 September 2023 Pages: 1365 - 1385

   

3. Alzheimer’s Disease: Novel Targets and Investigational Drugs for Disease Modification

   • Jeffrey L. Cummings
   • Amanda M. Leisgang Osse
   • Jefferson W. Kinney

   Review Article Open access 20 September 2023 Pages: 1387 - 1408

   

4. Pharmacotherapy for Dravet Syndrome: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials

   • Simona Lattanzi
   • Eugen Trinka
   • Francesco Brigo

   Systematic Review Open access 11 September 2023 Pages: 1409 - 1424

   

5. Vutrisiran: A Review in Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis

   • Tina Nie
   • Young-A Heo
   • Matt Shirley

   Adis Drug Evaluation 20 September 2023 Pages: 1425 - 1432

   

6. Befotertinib: First Approval

   • Hannah A. Blair

   AdisInsight Report 26 September 2023 Pages: 1433 - 1437

   

7. Talquetamab: First Approval

   • Susan J. Keam

   AdisInsight Report 04 October 2023 Pages: 1439 - 1445

   

8. Avacincaptad Pegol: First Approval

   • Connie Kang

   AdisInsight Report 09 October 2023 Pages: 1447 - 1453

   

9. Correction to: Birch Bark Extract: A Review in Epidermolysis Bullosa

   • Young-A Heo

   Correction 21 September 2023 Pages: 1455 - 1455

10. Correction to: Ritlecitinib: First Approval

    • Hannah A. Blair

    Correction Open access 05 October 2023 Pages: 1457 - 1457